
BAP1 - Wikipedia
BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase) is a deubiquitinating enzyme that in humans is encoded by the BAP1 gene. [5] [6] BAP1 encodes an 80.4 kDa nuclear …
BAP1 gene - MedlinePlus
The BAP1 gene provides instructions for making a protein called ubiquitin carboxyl-terminal hydrolase BAP1 (shortened to BAP1). This protein functions as a deubiquitinase, which means …
BAP1 Tumor Predisposition Syndrome - GeneReviews® - NCBI Bookshelf
Oct 13, 2016 · BAP1 tumor predisposition syndrome (BAP1-TPDS) is associated with increased risk for a specific skin lesion, BAP1-inactivated melanocytic tumor (BIMT; formerly called …
BAP1 Gene - GeneCards | BAP1 Protein | BAP1 Antibody
Dec 24, 2024 · BAP1 is a deubiquitylase thought to be a key regulator of many cancer-associated pathways. Germline alterations in BAP1 have been characterized as predisposing variants to …
Pathology Outlines - BAP1
BAP1 is functionally a tumor suppressor (Proc Natl Acad Sci USA 2014;111:285) BAP1 is a deubiquitinase that associates with multiprotein complexes that regulate key cellular pathways, …
抑癌基因-BAP1 - 知乎 - 知乎专栏
brca1关联蛋白1(bap1)是一种泛素蛋白羧基末端水解酶,已被确立为肿瘤抑制因子,利用其去泛素化活性来调节许多生物过程,包括dna损伤修复,细胞周期控制,染色质修饰,程序性细胞 …
BAP1 tumor predisposition syndrome | City of Hope
Nov 15, 2021 · BAP1 tumor predisposition syndrome, also known as BAP1-TPDS or COMMON syndrome, is an inherited genetic disorder that may increase the risk of certain types of …
An overview of BAP1 biological functions and current therapeutics
In this review, we summarize the current state of knowledge regarding the biological functions of BAP1, potential use of BAP1 signature in therapeutics, and advances in the field of targeted …
BAP1: Not just a BRCA1-associated protein - PubMed
BRCA1-Associated Protein 1 (BAP1) is a ubiquitin carboxy-terminal hydrolase that has been established as a tumor suppressor, utilizing its deubiquitinating activity to regulate a number of …
BAP1 tumor predisposition syndrome - MedlinePlus
BAP1 tumor predisposition syndrome is caused by mutations in the BAP1 gene. The BAP1 protein acts as a tumor suppressor, which means it helps prevent cells from growing and …
Roles and mechanisms of BAP1 deubiquitinase in tumor suppression
Jan 18, 2021 · BAP1 belongs to the deubiquitinase superfamily of enzymes, which are responsible for the maturation and turnover of ubiquitin as well as the reversal of substrate …
BAP1 tumor predisposition syndrome is an inherited disorder that increases the risk of a variety of cancerous (malignant) and noncancerous (benign) tumors, most commonly certain types of …
BAP1 and cancer - Nature Reviews Cancer
Feb 14, 2013 · Recent findings indicate that germline BAP1 mutations cause a novel cancer syndrome that is characterized, at least in the affected families that have been studied so far, …
霍乱弧菌生物被膜发育与环境调控 - 中科院微生物研究所 - Free考 …
基质蛋白包括RbmA、RbmC、Bap1,它们的基因分布在两个vps基因簇之间 ,被认为是生物被膜的骨架,粘合生物被膜中的组成部分,包括介质表面、细菌菌体、VPS、eDNA等。
Roles and mechanisms of BAP1 deubiquitinase in tumor suppression
BAP1 exerts its function through highly regulated deubiquitination of its substrates. As such, BAP1 orchestrates chromatin-associated processes including gene expression, DNA replication, and …
BAP1: Not just a BRCA1-associated protein - ScienceDirect
Nov 1, 2020 · BAP1 is a multifaceted tumor suppressor gene that regulates a wide variety of processes that are implicated in cancer.
BAP1 Mesothelioma: Gene Alterations and Clinical Implications
BAP1 alterations significantly impact mesothelioma prognosis and treatment. Patients with BAP1-deficient tumors often exhibit distinct clinical characteristics, including a more indolent disease …
MBD5 and MBD6 stabilize the BAP1 complex and promote BAP1 …
Sep 30, 2022 · We characterize MBD5 and MBD6 as important regulators of the BAP1 complex and maintain its transcriptional landscape, shedding light on the therapeutic potential of …
肾癌预后因素分析 - 知乎 - 知乎专栏
肾细胞癌简称肾癌,是肾实质肿瘤中最常见的一种恶性肿瘤。据统计,近30 年全球肾癌的发病率以每年3% 的速度增长;我国每年新增肾癌患者达8 万,每年因肾癌死亡的人数超过2 万。在临 …
樊嘉团队在肝肿瘤研究方面再获重大新突破 首次系统揭示肝内胆管 …
在该研究中,樊嘉院士团队建立了以蛋白质组为核心肝内胆管癌患者的分子分型:炎症型(s1)、间质型(s2)、代谢型(s3)和分化型(s4),这四个亚型在基因组、免疫微环境、治疗策略、临床 …